A DIVISION OF ALL HEALTH MEDICAL GROUP - VIRTUAL CONSULTS AVAILABLE 7 DAYS A WEEK
Text or Call 551-309-3555
Estrogen receptors are present throughout the entire body, including the brain, heart, bones, skin, joints, bladder, and blood vessels. When estrogen levels decline during perimenopause and menopause, these receptors are affected—impacting multiple body systems. This is why hormonal changes can lead to a wide range of symptoms beyond hot flashes, influencing sleep, mood, metabolism, bone health, and overall well-being.
At our practice, every patient receives a thoughtfully personalized experience. Our board-certified clinicians take the time to understand your unique symptoms, health history, and goals to design a tailored treatment plan. Using both hormone and non-hormone therapies, we provide comprehensive care that addresses the full spectrum of perimenopause and menopause symptoms.

Cash price available as well simply call or text 551-309-3555

Your relief is just a visit away
Please reach us at via text | call 551-309-3555
Perimenopause is the transitional period characterized by hormonal fluctuations and menstrual irregularities leading up to menopause, while menopause is the permanent cessation of menstruation, confirmed retrospectively after 12 consecutive months of amenorrhea.
The menopausal transition typically begins at a mean age of 46-47 years and lasts approximately 4 years on average, though duration varies considerably between individuals. The early menopausal transition is marked by menstrual cycle variability (≥7-day difference in consecutive cycle lengths), while the late transition is characterized by amenorrhea lasting 60 days or longer. Natural menopause occurs at a mean age of 51.4 years with 90% of women experiencing menopause between ages 45 and 56 years. The median age is reported as 51.3 years in the United States
The American College of Obstetricians and Gynecologists explains that perimenopause is diagnosed clinically based on age, menstrual pattern changes, and symptoms—not through laboratory testing alone. The menopausal transition is marked by fluctuating hormone levels as ovarian function begins to slow down, with serum levels of estradiol and progesterone decreasing and follicle-stimulating hormone levels increasing, resulting in physiologic changes and clinical symptoms. Vasomotor symptoms (hot flushes) and vaginal symptoms are the most closely associated with the hormonal changes of the menopausal transition.
Yes, hormone replacement therapy (HRT) is considered safe for appropriate candidates in 2026, particularly for younger postmenopausal women (under age 60 or within 10 years of menopause) with bothersome vasomotor symptoms and no contraindications. The understanding of HRT safety has evolved significantly since the initial Women's Health Initiative (WHI) findings in 2002, with current evidence emphasizing individualized treatment based on timing, formulation, and patient characteristics.
Yes, there are multiple effective non-hormonal treatment options
A consultation with one of our board-certified clinicians can take place in person or virtually before starting hormone replacement therapy (HRT). The consultation will focus on confirming menopausal symptoms, ruling out contraindications, obtaining and establishing baseline health markers. Our menopause specialists combine clinical history, risk assessment, and targeted labs rather than relying on labs alone.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.